Meet the Distinguished Vaccine Development Speaking Faculty:
Steven Buchsbaum, Senior Program Officer, Bill & Melinda Gates Foundation
Dexiang Chen, PhD, Senior Technical Officer, Program for Appropriate Technology in Health (PATH)
Graham Clarke, MSc, MBA, FCMA, CEO, ImmunoBiology Ltd
John D. Clements, PhD, Professor and Chair, Department of Microbiology and Immunology, Tulane University School of Medicine
Stanley L. Hem, PhD, Professor, Purdue University
Jee Loon Look, PhD, Director of Formulation Development, Iomai Vaccines
Professor Nikolai Petrovsky MBBS, PhD, FRACP, Director of Endocrinology, Flinders Medical Centre
Lee K. Roberts, PhD, Vice President of Operations, ODC Therapy, Inc.
Kimber L. Poffenberger, PhD, Vice President, Regulatory Affairs, IOMAI CORPORATION
Theodore W. Randolph, PhD, Gillespie Professor of Bioengineering, UNIVERSITY OF COLORADO, BOULDER
Alain Rolland, PharmD, PhD, Senior Vice President, Product Development, Vical Incorporated
Ian C. Boulton, Former Development Scientist, Formulation & Stability, SANOFI-PASTEUR, President and Chief Scientific Officer, The IMAGO GROUP
Manmohan Singh, PhD, Director of Vaccines Research, Novartis Vaccines
Li Shi, PhD, Associate Director, Pharmaceutical Research & Development, MERCK & COMPANY
Lance K Gordon, PhD, Director and CEO, IMMUNOBIOLOGICS CORPORATION
Satyanarayana Somavarapu, PhD, Research Fellow, University of London School of Pharmacy
Copyright 2003-2006 IIR Holdings, Ltd. All rights Reserved